Search Results - Jeffrey Chou
- Showing 1 - 5 results of 5
-
1
Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient mice. by Jeffrey Chou, Matthew P Fitzgibbon, Christie-Lynn L Mortales, Andrea M H Towlerton, Melissa P Upton, Raymond S Yeung, Martin W McIntosh, Edus H Warren
Published in PLoS ONE (2013-01-01)Get full text
Article -
2
Lifileucel tumor‐infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors by Harriet Kluger, Götz Ulrich Grigoleit, Sajeve Thomas, Evidio Domingo‐Musibay, Jason A Chesney, Miguel F Sanmamed, Theresa Medina, Mirjana Ziemer, Eric Whitman, Friedrich Graf Finckenstein, Brian Gastman, Jeffrey Chou, Xiao Wu, Giri Sulur, Rana Fiaz, Rongsu Qi, Amod A Sarnaik
Published in Cancer Communications (2025-10-01)Get full text
Article -
3
776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study by James Larkin, Harriet Kluger, Omid Hamid, Jeffrey Weber, Amod A Sarnaik, Brian Gastman, Jeffrey Chou, John M Kirkwood, Eric Whitman, Martin Wermke, Evidio Domingo-Musibay, Theresa Medina, Sajeve Thomas, Wen Shi, Xiao Wu, Jason A Chesney, Giri Sulur, Friedrich Graf Finckenstein
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
4
778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectabl... by Gino K In, James Larkin, Yazan Samhouri, Marcus Butler, Victoria Atkinson, Jeffrey Chou, Juan Martin-Liberal, Patrick Terheyden, Sajeve Thomas, Wen Shi, Xiao Wu, Andrew S Poklepovic, Young Hong, Giri Sulur, Friedrich Graf Finckenstein, John B Haanen, Andrew JS Furness, Philip Lammers, Ryan H Nguyen, Idit Peretz
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
5
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma by Min Yi, Robert L Ferris, Ammar Sukari, Brian Gastman, Jeffrey Chou, Rom S Leidner, Sylvia M Lee, Christine H Chung, Antonio Jimeno, Rana Fiaz, Ezra E W Cohen, Juneko E Grilley-Olson, Friedrich Graf Finckenstein, Melissa Catlett, Jorge J Nieva, Rebecca Redman, Stuart J Wong, Victoria M Villaflor, Jamal Misleh
Published in Journal for ImmunoTherapy of Cancer (2025-08-01)Get full text
Article
